Financhill
Back

Taysha Gene Therapies Stock Predictions

Taysha Gene Therapies Stock Forecast

  • Is Taysha Gene Therapies Stock Undervalued?
    The current Taysha Gene Therapies [TSHA] share price is $2.61. The Score for TSHA is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • TSHA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Taysha Gene Therapies Stock Go Up Next Year?

Data Unavailable

Taysha Gene Therapies Stock Rating

Data Unavailable

Taysha Gene Therapies Stock Price History

Is TSHA stock going to rise?

  • The current trend is moderately bullish and TSHA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tayshagtx.com

52-Week Data

52-Week High:
4.32
52-Week Low:
1.05

Prediction Charts

Market Cap:
559.2M
Price in USD:
2.61
Volume:
3.1M
Beta:
0.90

Technical Analysis

SMA50:
1.88
SMA100:
1.77
SMA200:
1.95
52-Wk Change:
-19.6%

Stock Predictions

  • Is Taysha Gene Therapies stock public?
    Yes, Taysha Gene Therapies is a publicly traded company.
  • What is the Taysha Gene Therapies stock quote today?
    The Taysha Gene Therapies stock price is 2.61 USD today.
  • How to buy Taysha Gene Therapies stock online?
    You can buy Taysha Gene Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-7 1.93 1.90 2.12 1.85
May-8 1.86 2.10 2.28 1.85
May-9 2.10 2.13 2.22 2.06
May-12 2.19 2.32 2.34 2.15
May-13 2.33 2.34 2.37 2.21
May-14 2.35 2.37 2.45 2.27
May-15 2.51 2.56 2.77 2.30
May-16 2.59 2.70 2.77 2.56
May-19 2.64 2.79 2.88 2.63
May-20 2.78 2.93 3.00 2.75
May-21 2.86 2.89 3.24 2.83
May-22 2.84 2.85 2.94 2.72
May-23 2.76 2.75 2.85 2.57
May-27 2.80 2.61 2.84 2.60

Taysha Gene Therapies Earnings

Data Unavailable

Taysha Gene Therapies Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.03 per share.

* Taysha Gene Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.